Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 2
Submit an article Journal homepage
314
Views
13
CrossRef citations to date
0
Altmetric
Letter to the Editor

Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves’ Ophthalmopathy, a Report of Three Cases

Thomas MaldineyDepartment of Internal Medicine, Dijon Bourgogne University Hospital, Dijon, FranceORCID Iconhttps://orcid.org/0000-0002-7514-2113
ORCID Icon,
Clémence DeschasseDepartment of Ophthalmology, Dijon Bourgogne University Hospital, Dijon, France
&
Philip BielefeldDepartment of Internal Medicine, Dijon Bourgogne University Hospital, Dijon, FranceCorrespondence[email protected]
Pages 281-284 | Received 17 Jun 2018, Accepted 05 Nov 2018, Published online: 20 Nov 2018

REFERENCES

  • Bahn RS. Graves’ ophthalmopathy. New Engl J Med. 2010;362(8):726–738.
  • Wiersinga WM. Advances in treatment of active, moderate-to-severe Graves’ ophthalmopathy. Lancet Diabetes Endocrinol. 2017;5(2):134–142. doi:10.1016/S2213-8587(16)30046-8.
  • Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158(3):273–285. doi:10.1530/EJE-07-0666.
  • Salvi M. Immunotherapy for Graves’ ophthalmopathy. Curr Opin Endocrinol Diabetes Obes. 2014;21:409–414. doi:10.1097/MED.0000000000000097.
  • Salvi M, Vannucchi G, Currò N, et al. Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves’ orbitopathy: a randomized controlled study. J Clin Endocrinol Metab. 2015;100(2):422–431. doi:10.1210/jc.2014-3014.
  • Wang C, Ning Q, Jin K, et al. Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis. BMC Ophthalmol. 2018;18(1):46. doi:10.1186/s12886-018-0679-4.
  • Pérez-Moreiras JV, Alvarez-López A, Gómez EC. Treatment of active corticosteroid-resistant graves’ orbitopathy. Ophthal Plast Reconstr Surg. 2014;30(2):162–167. doi:10.1097/IOP.0000000000000037.
  • Russell DJ, Wagner LH, Seiff SR. Tocilizumab as a steroid sparing agent for the treatment of Graves’ orbitopathy. Am J Ophthalmol Case Rep. 2017;7:146–148. doi:10.1016/j.ajoc.2017.07.001.
  • NCT01297699. Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) (GRC). https://clinicaltrials.gov/ct2/show/NCT01297699
  • Garrity JA, Fatourechi V, Bergstralh EJ, et al. Graves’ ophthalmopathy. Results of transantral orbital decompression in 428 patients with severe Graves’ ophthalmopathy. Am J Ophthalmol. 1994;116:533–547.
  • Campi I, Vannucchi G, Salvi M. Endocrine Dilemma: management of Graves’ Orbitopathy. Eur J Endocrinol. 2016;175(3):R117–133. doi:10.1530/EJE-15-1164.
  • Eckstein AK, Lösch C, Glowacka D, et al. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol. 2009;93(8):1052–1056. doi:10.1136/bjo.2007.137265.
  • Ponto KA, Binder H, Diana T, et al. Prevalence, phenotype, and psychosocial well-being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy. Thyroid. 2015;25(8):942–948. doi:10.1089/thy.2015.0031.
  • Khoo DH, Eng PH, Ho SC, et al. Graves’ ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000;10(12):1093–1100. doi:10.1089/thy.2000.10.1093.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.